skip to Cookie NoticeSkip to contents

Your health and safety remain our top priority: Learn about our Safe Care Commitment | Use our Prescreen app before arrival for faster entry | Read the COVID-19 Vaccine FAQs

Header Skipped.

Arthritis and Joint Disease Research

Therapeutics Group

Our therapeutics group in the Center for Arthritis and Joint Diseases has an international reputation for evaluation of new treatments for rheumatic disease. The group's major interest is in therapies for rheumatoid arthritis. This group has extensively evaluated many of the major therapies used in the treatment of the disease including methotrexate, cyclosporin A, leflunomide, combination therapies and new biologics including TNF inhibitors. The group has a very active clinical trials program and is at the forefront of studying new therapies for rheumatoid arthritis.


For over a century, a leader in patient care, medical education and research, with expertise in virtually every specialty of medicine and surgery.

About BWH